(CYRX) Cryoport - Ratings and Ratios

Cryoport, Inc. (NASDAQ:CYRX) specializes in temperature-controlled supply chain solutions for the biopharma, pharma, animal health, and human reproductive medicine sectors globally. The company serves clients across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, offering a comprehensive suite of products and services tailored to the precise temperature requirements of biological materials.

The company’s product portfolio includes the Cryoport Express Shippers, designed for reliable temperature control during transport; the Cryoport ELITE series, which features advanced solutions like the -80°C Gene Therapy Shipper and the Cryosphere Shipper for ultra-low temperature applications. It also provides consulting services, including thermal and shipping system qualifications, custom packaging development, and bioservices such as controlled temperature storage, fulfillment, and secondary packaging. Additionally, Cryoport offers specialized solutions like CRYOGENE for pre-clinical biological materials management and CRYOPD for temperature-controlled logistics.

Cryoport further expands its offerings with MVE Biological Solutions’ cryogenic systems, including the Fusion and Vario freezers, which support a range of temperatures from -20°C to -150°C. The company also provides Cryoshuttle for dedicated local transportation, IntegriCell services for apheresis/leukapheresis collection and cryo-process optimization, and Tec4Med solutions. Its services encompass biological specimen cryopreservation, archiving, tracking, and transportation, as well as short-term logistics and engineering consulting.

Founded in 1999 and headquartered in Brentwood, Tennessee, Cryoport has established itself as a key player in the temperature-controlled logistics and storage market. The company’s focus on innovation and precision has enabled it to meet the growing demands of the biopharma and life sciences industries. Web URL: https://www.cryoportinc.com